ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 19, Pages 4038-4048
Publisher
American Society of Hematology
Online
2012-09-15
DOI
10.1182/blood-2012-05-429050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
- (2012) A Ptasinska et al. LEUKEMIA
- The role of CBF in AML1-ETO's activity
- (2011) S. Park et al. BLOOD
- Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia
- (2011) S. M. Kornblau et al. BLOOD
- Promotion and maintenance of leukemia by ERG
- (2011) S. Tsuzuki et al. BLOOD
- ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification
- (2011) S. Taoudi et al. GENES & DEVELOPMENT
- Acute myeloid leukemia: A central role for the ETS factor ERG
- (2011) Joost H.A. Martens INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG
- (2011) L H Mochmann et al. ONCOGENE
- The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
- (2011) L. Wang et al. SCIENCE
- Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity
- (2010) C. Wichmann et al. BLOOD
- PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
- (2010) Kankan Wang et al. CANCER CELL
- PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
- (2010) Joost H.A. Martens et al. CANCER CELL
- Combinatorial Transcriptional Control In Blood Stem/Progenitor Cells: Genome-wide Analysis of Ten Major Transcriptional Regulators
- (2010) Nicola K. Wilson et al. Cell Stem Cell
- Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
- (2010) Gong-Hong Wei et al. EMBO JOURNAL
- CBF is critical for AML1-ETO and TEL-AML1 activity
- (2009) L. Roudaia et al. BLOOD
- Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation
- (2009) Kairong Cui et al. Cell Stem Cell
- ERGExpression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis ofERG, MN1, andBAALCTranscript Levels Using Oligonucleotide Microarrays
- (2009) Klaus H. Metzeler et al. JOURNAL OF CLINICAL ONCOLOGY
- Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes
- (2009) Colin Kwok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage
- (2009) E. A. Kruse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells
- (2008) Stephen J Loughran et al. NATURE IMMUNOLOGY
- AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
- (2008) Alessandro Gardini et al. PLoS Genetics
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More